Paine Emily Allen, Appenroth Max, Scheim Ayden, Goldrich Madison, Giguere Rebecca, Sandfort Theodorus
Department of Psychiatry and Sociomedical Sciences, Columbia University, New York, NY.
Institute of Public Health, Charité Universitätsmedizin Berlin, Berlin, Germany.
J Acquir Immune Defic Syndr. 2024 Dec 15;97(5):471-476. doi: 10.1097/QAI.0000000000003512.
We assessed access to pre-exposure prophylaxis (PrEP) and interest in integration of PrEP with gender-affirmative care in a global sample of transmasculine persons.
Transmasculine persons (N = 590) aged 18 years and above from 57 countries completed a brief online survey from April to July 2022 about sexual behavior, knowledge, and interest in PrEP, current access to PrEP and gender-affirmative care, and preferred context for accessing PrEP. Descriptive analyses were stratified by country income group.
Most participants (54.4%) lived near a health center offering care to trans people. Overall, 1.9% of respondents reported ever receiving a positive HIV test result. Among those who had not (n = 579), more than a third reported engaging in receptive sex in the past year (35.2%) or anticipated doing so in the next year (41.5%), 86.9% had never received information about HIV prevention specific to transmasculine people, and 76.3% had heard of PrEP. Among those who had heard of PrEP (n = 440), only 18.9% had discussed or been offered it by a provider, and only 3.6% were currently taking it-yet 67.9% who had heard of it but were not using it would "definitely" (28.5%) or "maybe" (39.4%) be interested in taking it were it available for free. Out of these participants, the majority (60.5%) preferred the idea of accessing PrEP from the same clinic where they received gender-affirming care.
Interventions are needed to improve PrEP access for transmasculine people globally. Clinics already providing gender-affirming care to trans people are acceptable clinical contexts to integrate such interventions.
我们在全球范围内的跨性别男性样本中,评估了暴露前预防(PrEP)的可及性以及将PrEP与性别肯定治疗相结合的意愿。
2022年4月至7月,来自57个国家的18岁及以上跨性别男性(N = 590)完成了一项简短的在线调查,内容包括性行为、对PrEP的了解和意愿、目前获得PrEP和性别肯定治疗的情况,以及获取PrEP的首选途径。描述性分析按国家收入组进行分层。
大多数参与者(54.4%)居住在有提供跨性别者护理的健康中心附近。总体而言,1.9%的受访者报告曾有过HIV检测呈阳性的结果。在未检测出阳性的人群中(n = 579),超过三分之一的人报告在过去一年有过接受性行为(35.2%)或预计在明年会有(41.5%),86.9%的人从未收到过针对跨性别男性的HIV预防信息,76.3%的人听说过PrEP。在听说过PrEP的人群中(n = 440),只有18.9%的人曾与医疗服务提供者讨论过PrEP或被提供过PrEP,目前只有3.6%的人正在服用PrEP——然而,在听说过PrEP但未服用的人群中,67.9%的人表示如果可以免费获得,“肯定”(28.5%)或“可能”(39.4%)会有兴趣服用。在这些参与者中,大多数(60.5%)倾向于在接受性别肯定治疗的同一家诊所获取PrEP。
需要采取干预措施,以改善全球跨性别男性获取PrEP的情况。已经为跨性别者提供性别肯定治疗的诊所是整合此类干预措施的合适临床场所。